Future of Healthcare: Implantable Drug Delivery Devices Market Expected to Reach $13.2 Billion by 2027 - AMR
Implantable Drug Delivery Devices Market by Material (Silicon and Others), Product Type Implantable Drug Eluting Stents
WILMINGTON, DELAWARE, UNITED STATES, June 6, 2024 /EINPresswire.com/ -- According to the report, the global implantable drug delivery devices industry garnered $10.09 billion in 2019, and is projected to generate $13.21 billion by 2027, manifesting a CAGR of 8.0% from 2020 to 2027.
๐๐ซ๐ข๐ฆ๐ ๐๐๐ญ๐๐ซ๐ฆ๐ข๐ง๐๐ง๐ญ๐ฌ ๐จ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก
Surge in prevalence of chronic conditions, increase in demand for minimally invasive devices, and unwanted pregnancies propel the growth of the global implantable drug delivery devices market. However, stringent government policies & regulations and probability of failure restrain the market growth. Contrarily, collaborative approach adopted by leading players presents new opportunities in the next few years.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐๐๐-๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ:
https://www.alliedmarketresearch.com/request-for-customization/449?reqfor=covid
๐๐ก๐ ๐ก๐จ๐ฌ๐ฉ๐ข๐ญ๐๐ฅ๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ ๐ฅ๐ฎ๐๐ซ๐๐ญ๐ข๐ฏ๐ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ
Based on end user, the hospitals segment accounted for the highest market share in 2019, holding more than half of the global implantable drug delivery devices market, and is expected to maintain its dominant position during the forecast period. Moreover, this segment is estimated to witness the highest CAGR of 8.9% from 2020 to 2027. This is attributed to multi-specialty or multi healing services provided in efficient and cost-effective manner. The report also offers a detailed analysis of segments including ambulatory surgery centers and clinics and others.
๐๐ก๐ ๐ข๐ฆ๐ฉ๐ฅ๐๐ง๐ญ๐๐๐ฅ๐ ๐๐จ๐ง๐ญ๐ซ๐๐๐๐ฉ๐ญ๐ข๐ฏ๐ ๐๐ซ๐ฎ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐๐ฏ๐ข๐๐๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐ก๐ ๐๐๐ฌ๐ญ๐๐ฌ๐ญ
By product type, the implantable contraceptive drug delivery devices segment is projected to portray the highest CAGR of 9.9% from 2020 to 2027, owing to surge in prevalence of unwanted pregnancy in recent years. However, the implantable drug-eluting stents segment accounted for the largest market share, contributing for nearly two-thirds of the total share of the global implantable drug delivery devices market in 2019, and will maintain its lead status throughout the forecast period. This is due to increase in adoption of implantable products for treating coronary artery disease.
๐๐ซ๐จ๐ฐ๐ข๐ง๐ ๐๐๐๐ ๐๐จ๐ซ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐ก๐๐ญ ๐๐ซ๐ ๐๐ข๐ง๐ข๐ฆ๐๐ฅ๐ฅ๐ฒ ๐๐ง๐ฏ๐๐ฌ๐ข๐ฏ๐
Because of all the advantages, minimally invasive medical procedures are becoming the preferred option for both patients and healthcare professionals. Compared to traditional surgical treatments, these procedures usually entail less discomfort, faster recovery times, and a lower chance of problems. This approach is well suited for implantable drug delivery devices, which may be placed with little surgical assistance and offer long-term therapeutic effects without requiring regular doctor visits. One major factor propelling the market's expansion is consumers' increasing demand for minimally invasive procedures.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/449
๐๐๐๐๐ข๐ง๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ
โช๏ธ Abbott Laboratories
โช๏ธ Bayer AG
โช๏ธ AbbVie Inc.
โช๏ธ Teleflex Incorporated
โช๏ธ Biotronik, Inc.
โช๏ธ Bausch Health Companies Inc.
โช๏ธ Medtronic Plc
โช๏ธ Merck & co., Inc.
โช๏ธ Boston Scientific Corporation
โช๏ธ Terumo Corporation
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
๐๐จ๐ง๐ญ๐๐๐ญ
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Intโl: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
David Correa
Allied Market Research
+ 18007925285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
![](https://www.einpresswire.com/tracking/article.gif?t=2&a=LRtlNeHtl14pqBoo&i=UmapscunsNPmhcxa)